Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

3.2%; RD = 2.2%, 95% CI −0.6–5.1%); and although the risk of failure tended to be lower in those treated with DP than for AL after 42 days of follow up, the difference did not reach statistical significance(2.0% vs. 5.8%; RD = 3.8%, 95% CI −0.2–7.8%), ( Table 3 ).

also in 75,868 other papers

The distribution of the serious adverse events was not significantly different in the two treatment groups, except that an increased incidence of abdominal pain with AL was of borderline significance.

also in 1,681 other papers